stella
beta
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment — Stella
Home
/
Hepatocellular Carcinoma
/
View on ClinicalTrials.gov
Recruiting
Back to Hepatocellular Carcinoma trials
Trial locations
(1 site)
China
Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality